Accessibility Menu
Gelesis logo

Gelesis

(OTC) GLSHQ

Current Price$0.00
Market Cap$100.00
Since IPO (2020)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Gelesis Financials at a Glance

Market Cap

$100.00

Revenue (TTM)

$12.14M

Net Income (TTM)

-$51.67M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-302.27 (Low)

Price

$0.00

Volume

1

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Jun 3, 2026

GLSHQ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Gelesis

Industry

Biotechnology

Employees

100

CEO

Yishai Zohar

Headquarters

Boston, MA 02116, US

GLSHQ Financials

Key Financial Metrics (TTM)

Gross Margin

-6.95%

Operating Margin

-472.72%

Net Income Margin

-216.48%

Return on Equity

31.43%

Return on Capital

-327.37%

Return on Assets

-53.99%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$100.00

Shares Outstanding

73.34M

Volume

1

Avg. Volume

8.333

Financials (TTM)

Gross Profit

-$7.45M

Operating Income

-$66.34M

EBITDA

-$39.68M

Operating Cash Flow

-$46.04M

Capital Expenditure

-$4.30M

Free Cash Flow

-$50.33M

Cash & ST Invst.

$7.91M

Total Debt

$61.88M

Gelesis Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2023YOY CHG

Revenue

$1.11M

-87.7%

Gross Profit

$609.00K

-85.5%

Gross Margin

55.01%

N/A

Market Cap

$100.00

N/A

Market Cap/Employee

$1.08

N/A

Employees

93

N/A

Net Income

-$7.68M

+39.0%

EBITDA

-$4.88M

+56.5%

Quarterly Fundamentals

Name
Q2 2023YOY CHG

Total Cash

$7.91M

-68.8%

Total Debt

$61.88M

+77.0%

Accounts Receivable

$9.56M

-32.2%

Inventory

$5.69M

-69.8%

Long Term Debt

$27.96M

-10.5%

Short Term Debt

$33.91M

+809.9%

Return on Assets

-53.99%

N/A

Return on Invested Capital

-2.31%

N/A

Free Cash Flow

$599.00K

+107.8%

Operating Cash Flow

$617.00K

+113.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GNBTGenerex Biotechnology Corporation
$0.00+0.00%
GTHRGeneThera, Inc.
$0.00+0.00%
CRYOAmerican CryoStem Corporation
$0.00-99.75%
CRXMGene Biotherapeutics, Inc.
$0.00+9900.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$17.87+0.02%
SPCXSpace Exploration Technologies
$153.23+0.00%
ONDSOndas
$7.83+0.02%
KEELKeel Infrastructure
$6.03+0.03%

Questions About GLSHQ

What is the current price of Gelesis?

Gelesis is trading at $0.00 per share.

What is the 52-week range for Gelesis?

Over the past 52 weeks, Gelesis has traded between $0.00 and $0.00.

How much debt does Gelesis have?

As of the most recent reporting period, Gelesis reported total debt of $62.26M.

How much cash does Gelesis have on hand?

Gelesis reported $7.41M in cash and cash equivalents in its most recent financial results.

What is Gelesis’s dividend yield?

Gelesis does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.